首页 > 最新文献

Contact Lens & Anterior Eye最新文献

英文 中文
Characterizing power profiles of a concentric ring multifocal contact lens for myopia management: a novel approach 一种用于近视治疗的同心环多焦点隐形眼镜的功率分布特征:一种新方法。
IF 3.7 3区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-12-01 DOI: 10.1016/j.clae.2025.102454
Annabelle J. Mawhinney , Phillip J. Buckhurst , Craig McNeile , Stephen D. Hall , Hetal D. Buckhurst
This study presents a systematic method for characterizing power profiles of concentric ring multifocal contact lenses (MFCL), specifically the MiSight® lens used in myopia management, and evaluates the potential of Multivariate Adaptive Regression Spline (MARS) modelling to extrapolate profiles across a full dioptric range.
Power profiles of eleven MiSight® lenses (−0.25D, then −1.00D to −10.00D in 1.00D steps) were measured using the NIMOevo® system. MiSight® lenses comprise four concentric zones, with zones 2 and 4 providing additional plus power. Centre thickness (CT) was measured using an immersive spectral-domain Optical Coherence Tomographer. Zonal boundaries were determined as asymptotes of a four-parameter sigmoidal function fitted to junctions between zones, average power within each zone was calculated between these boundaries.
MARS was trained on the measured power profiles and used to generate theoretical power profiles for intermediate powers. These were validated against independently measured lenses with matching labelled powers (−1.50D, −3.50D and −6.50D).
The proposed method identified consistent zonal boundaries across labelled powers, with minor power-dependent variations. CT correlated significantly with labelled power (r = 0.78). Zone 2 addition powers were consistent, while zone 4 demonstrated a decreasing trend with increasing negative power. The MARS accurately modeled boundary locations and addition powers.
This framework offers a systematic approach for analyzing zonal MFCL power profiles, addressing the method for determining zonal boundaries. Additional plus power provided by MiSight® lenses varies across the two zones, with a pronounced effect of reducing addition power in zone 4. MARS modelling allowed extrapolation of power profiles and warrants further investigation.
本研究提出了一种系统的方法来表征同心圆多焦隐形眼镜(MFCL)的功率分布,特别是用于近视治疗的MiSight®隐形眼镜,并评估了多元自适应回归样条(MARS)模型在整个屈光度范围内推断轮廓的潜力。使用NIMOevo®系统测量了11个MiSight®镜头(-0.25D,然后-1.00D至-10.00D,分1.00D步)的功率分布。MiSight®镜头包括四个同心区域,区域2和4提供额外的附加功率。中心厚度(CT)采用沉浸式光谱域光学相干层析仪测量。区域边界被确定为四参数s型函数的渐近线,拟合到区域之间的连接处,计算这些边界之间每个区域内的平均功率。根据测量的功率分布对MARS进行训练,并用于生成中等功率的理论功率分布。这些是通过独立测量的具有匹配标记功率(-1.50D, -3.50D和-6.50D)的透镜进行验证的。所提出的方法确定了标记功率之间一致的区域边界,具有较小的功率依赖变化。CT与标记功率显著相关(r = 0.78)。区域2的加法幂基本一致,而区域4的加法幂随负幂的增加呈下降趋势。MARS精确地模拟了边界位置和加法。该框架提供了一个系统的方法来分析层间MFCL功率分布,解决了确定层间边界的方法。MiSight®透镜提供的额外附加功率在两个区域之间有所不同,在区域4中具有明显的降低附加功率的效果。火星模型允许外推功率分布,并保证进一步调查。
{"title":"Characterizing power profiles of a concentric ring multifocal contact lens for myopia management: a novel approach","authors":"Annabelle J. Mawhinney ,&nbsp;Phillip J. Buckhurst ,&nbsp;Craig McNeile ,&nbsp;Stephen D. Hall ,&nbsp;Hetal D. Buckhurst","doi":"10.1016/j.clae.2025.102454","DOIUrl":"10.1016/j.clae.2025.102454","url":null,"abstract":"<div><div>This study presents a systematic method for characterizing power profiles of concentric ring multifocal contact lenses (MFCL), specifically the MiSight® lens used in myopia management, and evaluates the potential of Multivariate Adaptive Regression Spline (MARS) modelling to extrapolate profiles across a full dioptric range.</div><div>Power profiles of eleven MiSight® lenses (−0.25D, then −1.00D to −10.00D in 1.00D steps) were measured using the NIMOevo® system. MiSight® lenses comprise four concentric zones, with zones 2 and 4 providing additional plus power. Centre thickness (CT) was measured using an immersive spectral-domain Optical Coherence Tomographer. Zonal boundaries were determined as asymptotes of a four-parameter sigmoidal function fitted to junctions between zones, average power within each zone was calculated between these boundaries.</div><div>MARS was trained on the measured power profiles and used to generate theoretical power profiles for intermediate powers. These were validated against independently measured lenses with matching labelled powers (−1.50D, −3.50D and −6.50D).</div><div>The proposed method identified consistent zonal boundaries across labelled powers, with minor power-dependent variations. CT correlated significantly with labelled power (r = 0.78). Zone 2 addition powers were consistent, while zone 4 demonstrated a decreasing trend with increasing negative power. The MARS accurately modeled boundary locations and addition powers.</div><div>This framework offers a systematic approach for analyzing zonal MFCL power profiles, addressing the method for determining zonal boundaries. Additional plus power provided by MiSight® lenses varies across the two zones, with a pronounced effect of reducing addition power in zone 4. MARS modelling allowed extrapolation of power profiles and warrants further investigation.</div></div>","PeriodicalId":49087,"journal":{"name":"Contact Lens & Anterior Eye","volume":"48 6","pages":"Article 102454"},"PeriodicalIF":3.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144250488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor: is the elimination of keratoconus in our hands? 致编辑的信:圆锥角膜的消除在我们手中吗?
IF 3.7 3区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-12-01 DOI: 10.1016/j.clae.2025.102472
Alejandro Tello , Virgilio Galvis
{"title":"Letter to the Editor: is the elimination of keratoconus in our hands?","authors":"Alejandro Tello ,&nbsp;Virgilio Galvis","doi":"10.1016/j.clae.2025.102472","DOIUrl":"10.1016/j.clae.2025.102472","url":null,"abstract":"","PeriodicalId":49087,"journal":{"name":"Contact Lens & Anterior Eye","volume":"48 6","pages":"Article 102472"},"PeriodicalIF":3.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144545762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving multifocal contact lens fitting by replicating their fitting guides using the SimVis Gekko visual simulator 通过使用SimVis Gekko视觉模拟器复制多焦点隐形眼镜的配戴指南来改进多焦点隐形眼镜的配戴。
IF 3.7 3区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-12-01 DOI: 10.1016/j.clae.2025.102468
Eduardo Esteban-Ibañez , Ainhoa Molina-Martín , Elena Martínez-Plaza , Carlos Dorronsoro , Enrique Gambra , David P. Piñero

Purpose

To evaluate the feasibility of implementing fitting guides for multifocal contact lenses (MCLs) using the SimVis Gekko visual simulator and, through a preliminary assessment with a novel metric (3D-VA, which integrates visual acuity at multiple distances and patient visual needs), determine whether this combined approach can optimise initial MCL selection.

Methods

Twenty presbyopic subjects participated in this study using two methods to select on-eye MCLs from 4 manufacturers: (1) using the first step of the fitting guide, according to the patient’s addition need, to provide the MCLs recommended by the manufacturer and, (2) using SimVis Gekko simulations to obtain MCLs providing better 3D-VA, between the first and the first-alternative step of the fitting guides. Clinical measurements and metric calculations (3D-VA, perceptual score module, and direct preference) were conducted to compare the visual performance of the on-eye MCLs selected by both methods when differences existed.

Results

SimVis Gekko selected the same combination of MCLs as the fitting guides in 59 % of the cases. In 28 %, SimVis Gekko chose the alternative step with differences greater than 0.05 in 3D-VA. In these latter cases, the 3D-VAs obtained with the on-eye MCLs indicated that SimVis Gekko selections were better in 62 % of cases, equal in 14 %, and worse in 24 %. The perceptual score module showed that SimVis Gekko selections were better in 62 % of cases, equal in 9 %, and worse in 29 %. The direct preference indicated that SimVis Gekko selections were better in 61 % of cases. Clinical measurements revealed that MCLs selected by SimVis Gekko had better Near Activity Visual Questionnaire scores than the fitting guide selection across all manufacturers (p = 0.02), indicating greater comfort and independence for near activities.

Conclusions

SimVis Gekko can effectively replicate fitting guide steps and, in combination with the 3D-VA metric, has the potential to become a tool that helps practitioners enhance MCL wearer satisfaction. This approach could improve the adoption and visual performance of MCLs among the presbyopic population, streamlining the fitting process.
目的:评估使用SimVis Gekko视觉模拟器实施多焦点隐形眼镜(MCL)配戴指南的可行性,并通过一种新的度量(3D-VA,它集成了多距离的视力和患者的视觉需求)进行初步评估,确定这种组合方法是否可以优化初始MCL选择。方法:20名老视眼受试者采用两种方法从4家厂家选择眼上mcl:(1)采用第一步配镜,根据患者的附加需要,提供厂家推荐的mcl;(2)采用SimVis Gekko模拟,在第一步配镜和第一步可选配镜之间,获得提供更好3D-VA的mcl。通过临床测量和度量计算(3D-VA、感知评分模块和直接偏好)来比较两种方法选择的对眼mcl在存在差异时的视觉表现。结果:SimVis Gekko在59%的病例中选择了相同的mcl组合作为拟合指南。28%的SimVis Gekko选择了3D-VA的替代步骤,差异大于0.05。在后一种情况下,用眼上mcl获得的3d -血管显示,62%的病例SimVis Gekko选择更好,14%相同,24%更差。知觉评分模块显示,62%的情况下SimVis Gekko选择更好,9%的情况下相同,29%的情况下更差。直接偏好表明SimVis Gekko选择在61%的情况下更好。临床测量显示,SimVis Gekko选择的mcl在近距离活动视觉问卷评分上优于小制造商选择的拟合指南(p = 0.02),表明近距离活动更舒适和独立。结论:SimVis Gekko可以有效地复制试装指导步骤,并且与3d - va度量相结合,有可能成为帮助从业者提高MCL佩戴者满意度的工具。这种方法可以提高mcl在老视眼人群中的采用率和视觉表现,简化拟合过程。
{"title":"Improving multifocal contact lens fitting by replicating their fitting guides using the SimVis Gekko visual simulator","authors":"Eduardo Esteban-Ibañez ,&nbsp;Ainhoa Molina-Martín ,&nbsp;Elena Martínez-Plaza ,&nbsp;Carlos Dorronsoro ,&nbsp;Enrique Gambra ,&nbsp;David P. Piñero","doi":"10.1016/j.clae.2025.102468","DOIUrl":"10.1016/j.clae.2025.102468","url":null,"abstract":"<div><h3>Purpose</h3><div>To evaluate the feasibility of implementing fitting guides for multifocal contact lenses (MCLs) using the SimVis Gekko visual simulator and, through a preliminary assessment with a novel metric (3D-VA, which integrates visual acuity at multiple distances and patient visual needs), determine whether this combined approach can optimise initial MCL selection.</div></div><div><h3>Methods</h3><div>Twenty presbyopic subjects participated in this study using two methods to select on-eye MCLs from 4 manufacturers: (1) using the first step of the fitting guide, according to the patient’s addition need, to provide the MCLs recommended by the manufacturer and, (2) using SimVis Gekko simulations to obtain MCLs providing better 3D-VA, between the first and the first-alternative step of the fitting guides. Clinical measurements and metric calculations (3D-VA, perceptual score module, and direct preference) were conducted to compare the visual performance of the on-eye MCLs<!--> <!-->selected by both methods when differences existed.</div></div><div><h3>Results</h3><div>SimVis Gekko selected the same combination of MCLs as the fitting guides in 59 % of the cases. In 28 %, SimVis Gekko chose the alternative step with differences greater than 0.05 in 3D-VA. In these latter cases, the 3D-VAs<!--> <!-->obtained with the on-eye MCLs indicated that SimVis Gekko selections were better in 62 % of cases, equal in 14 %, and worse in 24 %. The perceptual score module showed that SimVis Gekko selections were better in 62 % of cases, equal in 9 %, and worse in 29 %. The direct preference indicated that SimVis Gekko selections were better in 61 % of cases. Clinical measurements revealed that MCLs<!--> <!-->selected by SimVis Gekko had better Near Activity Visual Questionnaire scores<!--> <!-->than the fitting guide selection across<!--> <!-->all manufacturers (p = 0.02), indicating greater comfort and independence for near activities.</div></div><div><h3>Conclusions</h3><div>SimVis Gekko can effectively replicate fitting guide steps and, in combination<!--> <!-->with the<!--> <!-->3D-VA metric, has the potential to become a tool that helps practitioners enhance MCL wearer satisfaction. This approach could improve the adoption and visual performance of MCLs among the presbyopic population,<!--> <!-->streamlining the fitting process.</div></div>","PeriodicalId":49087,"journal":{"name":"Contact Lens & Anterior Eye","volume":"48 6","pages":"Article 102468"},"PeriodicalIF":3.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144318444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-Demodex activity of castor oil confirmed in an ex vivo study 蓖麻油抗蠕形螨活性在离体研究中得到证实。
IF 3.7 3区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-12-01 DOI: 10.1016/j.clae.2025.102471
Catherine J. Jennings , Jordan M. Cooper , Kalika Bandamwar , Etty Bitton , Jennifer P. Craig

Purpose

Periocular castor oil application shows possible benefits in managing Demodex blepharitis based on visibly reduced cylindrical dandruff at the base of the eyelashes, but the antidemodectic mechanism remains unclear. This research sought to establish Demodex mite susceptibility to castor oil directly in a controlled, ex vivo study.

Methods

Motile Demodex mites from epilated eyelashes with visible cylindrical dandruff were exposed to 5 µL aliquots of one of four castor oil or tea tree oil-based preparations, or remained unexposed (negative control). Adult Demodex mite motility was confirmed by high magnification microscopy every 5 min for up to 480 min post-exposure and survival time recorded when movement ceased. Tested oils were 100% cold-pressed castor oil, a proprietary castor oil preparation containing identical castor oil combined with manuka and kanuka oils, and 100% and 50% tea tree oil as positive controls.

Results

Survival time in the negative control group exceeded 480 min. All tested oils exhibited shortened mite survival time relative to the negative control (p < 0.05 in all cases). Survival times for 59 mites from 12 participants were plotted for the 5 experimental groups. Undiluted and proprietary castor oil preparations exhibited median (interquartile range; IQR) survival times of 235 (200–285) and 325 (240–405) minutes, respectively, with no significant difference between groups (p > 0.05). A single mite from each castor oil group survived beyond 480 min. Positive controls exhibited median (IQR) survival times of 5 (5–10) mins for 100% tea tree oil and 20 (15–25) mins, for 50% tea tree oil.

Conclusions

Castor oil alone, or in proprietary form supplemented with manuka and kanuka oils, reduced Demodex survival over an 8-hour period. Outcomes suggest extended duration exposure to castor oil, such as in overnight application, has demodecidal activity that could contribute to Demodex blepharitis management.
目的:眼周蓖麻油应用显示在管理蠕形螨眼炎的基础上明显减少圆柱状头皮屑,但抗蠕形螨机制尚不清楚。本研究旨在建立蠕形螨对蓖麻油的敏感性直接控制,离体研究。方法:将有明显圆柱状头皮屑的脱毛睫毛中的蠕形螨暴露于5µL等份的蓖麻油或茶树油基制剂中,或不暴露(阴性对照)。暴露后480分钟内,每隔5分钟用高倍显微镜观察蠕形螨成虫的运动,并记录其停止运动时的存活时间。测试的油是100%冷榨蓖麻油,一种专有的蓖麻油制剂,含有相同的蓖麻油和麦卢卡和卡努卡油,以及100%和50%的茶树油作为阳性对照。结果:阴性对照组螨体存活时间均超过480 min,与阴性对照组相比,所有试验油的螨体存活时间均缩短(p < 0.05)。每个蓖麻油组都有一只螨存活超过480分钟。阳性对照显示,100%茶树油组的中位(IQR)存活时间为5(5-10)分钟,50%茶树油组的中位(IQR)存活时间为20(15-25)分钟。结论:单独使用蓖麻油,或添加麦卢卡油和卡努卡油的专有形式,可降低蠕形螨在8小时内的存活率。结果表明,长时间暴露于蓖麻油,如夜间应用,具有杀蠕形螨活性,可能有助于蠕形螨眼炎的管理。
{"title":"Anti-Demodex activity of castor oil confirmed in an ex vivo study","authors":"Catherine J. Jennings ,&nbsp;Jordan M. Cooper ,&nbsp;Kalika Bandamwar ,&nbsp;Etty Bitton ,&nbsp;Jennifer P. Craig","doi":"10.1016/j.clae.2025.102471","DOIUrl":"10.1016/j.clae.2025.102471","url":null,"abstract":"<div><h3>Purpose</h3><div>Periocular castor oil application shows possible benefits in managing <em>Demodex</em> blepharitis based on visibly reduced cylindrical dandruff at the base of the eyelashes, but the antidemodectic mechanism remains unclear. This research sought to establish <em>Demodex</em> mite susceptibility to castor oil directly in a controlled, <em>ex vivo</em> study.</div></div><div><h3>Methods</h3><div>Motile <em>Demodex</em> mites from epilated eyelashes with visible cylindrical dandruff were exposed to 5 µL aliquots of one of four castor oil or tea tree oil-based preparations, or remained unexposed (negative control). Adult <em>Demodex</em> mite motility was confirmed by high magnification microscopy every 5 min for up to 480 min post-exposure and survival time recorded when movement ceased. Tested oils were 100% cold-pressed castor oil, a proprietary castor oil preparation containing identical castor oil combined with manuka and kanuka oils, and 100% and 50% tea tree oil as positive controls.</div></div><div><h3>Results</h3><div>Survival time in the negative control group exceeded 480 min. All tested oils exhibited shortened mite survival time relative to the negative control (p &lt; 0.05 in all cases). Survival times for 59 mites from 12 participants were plotted for the 5 experimental groups. Undiluted and proprietary castor oil preparations exhibited median (interquartile range; IQR) survival times of 235 (200–285) and 325 (240–405) minutes, respectively, with no significant difference between groups (p &gt; 0.05). A single mite from each castor oil group survived beyond 480 min. Positive controls exhibited median (IQR) survival times of 5 (5–10) mins for 100% tea tree oil and 20 (15–25) mins, for 50% tea tree oil.</div></div><div><h3>Conclusions</h3><div>Castor oil alone, or in proprietary form supplemented with manuka and kanuka oils, reduced <em>Demodex</em> survival over an 8-hour period. Outcomes suggest extended duration exposure to castor oil, such as in overnight application, has demodecidal activity that could contribute to <em>Demodex</em> blepharitis management.</div></div>","PeriodicalId":49087,"journal":{"name":"Contact Lens & Anterior Eye","volume":"48 6","pages":"Article 102471"},"PeriodicalIF":3.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144568028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Randomized contralateral eye study of myopia control between aspheric multifocal soft contact lens and orthokeratology in children 非球面多焦点软性接触镜与角膜塑形术对儿童近视控制的随机对侧眼研究。
IF 3.7 3区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-12-01 DOI: 10.1016/j.clae.2025.102508
Ruru Chen , Tianhui Chen , Weiwei Lu , Yue Li , Jiawei Li , Tiankun Li , Hengli Lian , Siping Chen , Colm McAlinden , Xiaoying Wang , Jinhai Huang

Background

This study aimed to compare myopia progression in children wearing an aspheric multifocal contact lens and an orthokeratology (OrthoK) lens.

Methods

A total of 65 participants, aged 9.70 ± 1.31 years, were fitted with an OrthoK lens in one randomly assigned eye and a multifocal soft contact lens in the contralateral eye for the first 6 months (period 1). Following this, contact lens wear was discontinued in both eyes for 1 month, after which the two lens-wearing methods were swapped between eyes and continued for another 6 months (period 2). Axial length (AL), spherical equivalent refraction (SER), central corneal thickness (CCT), and central choroidal thickness (CChT) were measured at the 0-, 6-, 7-, 13-, and 14-month visits. AL and SER were the primary outcome measures.

Results

For the OrthoK and multifocal soft lens, AL elongation was 0.14 ± 0.11 mm and 0.23 ± 0.12 mm, respectively, after period 1. AL elongation for the OrthoK and multifocal lens was 0.12 ± 0.19 mm and 0.20 ± 0.13 mm, respectively, after period 2. The SER change for the OrthoK and multifocal lens was −0.20 ± 0.27 D and −0.33 ± 0.30 D after period 1 and −0.26 ± 0.40 D and −0.36 ± 0.46 D after period 2, respectively. No significant differences were observed between the two treatment groups (all P > 0.05).

Conclusions

During the 14-month observation period, no statistically significant differences in myopia progression were found between the aspheric multifocal contact lens and the OrthoK lens. Further longitudinal observation is necessary to characterize the disparities in long-term myopia-control efficacy between the two intervention strategies.

Trial registration

ChiCTR, ChiCTR2000041520. Registered 27 December 2020, https://www.chictr.org.cn/ChiCTR2000041520. Retrospectively registered.
背景:本研究旨在比较儿童配戴非球面多焦点隐形眼镜和角膜塑形镜(OrthoK)的近视进展。方法:65名参与者,年龄9.70±1.31岁,在前6个月(第一阶段)随机选择一只眼配戴OrthoK晶状体,对侧眼配戴多焦软性接触镜。在此之后,两只眼睛停止佩戴隐形眼镜一个月,之后在两只眼睛之间交换两种隐形眼镜佩戴方式,并继续佩戴6个月(第二阶段)。在第0、6、7、13和14个月随访时测量轴长(AL)、球面等效屈光度(SER)、角膜中央厚度(CCT)和脉络膜中央厚度(CChT)。AL和SER是主要结局指标。结果:对于OrthoK和多焦软性晶状体,第1期后AL伸长分别为0.14±0.11 mm和0.23±0.12 mm。第2期后,OrthoK和多焦晶状体的AL延伸率分别为0.12±0.19 mm和0.20±0.13 mm。OrthoK和多焦晶状体的SER变化在第1周期后分别为-0.20±0.27 D和-0.33±0.30 D,在第2周期后分别为-0.26±0.40 D和-0.36±0.46 D。两组间比较差异无统计学意义(P < 0.05)。结论:在14个月的观察期内,非球面多焦点隐形眼镜与OrthoK隐形眼镜的近视进展无统计学差异。进一步的纵向观察是必要的,以表征两种干预策略之间长期近视控制效果的差异。试验注册号:ChiCTR, ChiCTR2000041520。2020年12月27日注册,https://www.chictr.org.cn/ChiCTR2000041520。回顾注册。
{"title":"Randomized contralateral eye study of myopia control between aspheric multifocal soft contact lens and orthokeratology in children","authors":"Ruru Chen ,&nbsp;Tianhui Chen ,&nbsp;Weiwei Lu ,&nbsp;Yue Li ,&nbsp;Jiawei Li ,&nbsp;Tiankun Li ,&nbsp;Hengli Lian ,&nbsp;Siping Chen ,&nbsp;Colm McAlinden ,&nbsp;Xiaoying Wang ,&nbsp;Jinhai Huang","doi":"10.1016/j.clae.2025.102508","DOIUrl":"10.1016/j.clae.2025.102508","url":null,"abstract":"<div><h3>Background</h3><div>This study aimed to compare myopia progression in children wearing an aspheric multifocal contact lens and an orthokeratology (OrthoK) lens.</div></div><div><h3>Methods</h3><div>A total of 65 participants, aged 9.70 ± 1.31 years, were fitted with an OrthoK lens in one randomly assigned eye and a multifocal soft contact lens in the contralateral eye for the first 6 months (period 1). Following this, contact lens wear was discontinued in both eyes for 1 month, after which the two lens-wearing methods were swapped between eyes and continued for another 6 months (period 2). Axial length (AL), spherical equivalent refraction (SER), central corneal thickness (CCT), and central choroidal thickness (CChT) were measured at the 0-, 6-, 7-, 13-, and 14-month visits. AL and SER were the primary outcome measures.</div></div><div><h3>Results</h3><div>For the OrthoK and multifocal soft lens, AL elongation was 0.14 ± 0.11 mm and 0.23 ± 0.12 mm, respectively, after period 1. AL elongation for the OrthoK and multifocal lens was 0.12 ± 0.19 mm and 0.20 ± 0.13 mm, respectively, after period 2. The SER change for the OrthoK and multifocal lens was −0.20 ± 0.27 D and −0.33 ± 0.30 D after period 1 and −0.26 ± 0.40 D and −0.36 ± 0.46 D after period 2, respectively. No significant differences were observed between the two treatment groups (all <em>P</em> &gt; 0.05).</div></div><div><h3>Conclusions</h3><div>During the 14-month observation period, no statistically significant differences in myopia progression were found between the aspheric multifocal contact lens and the OrthoK lens. Further longitudinal observation is necessary to characterize the disparities in long-term myopia-control efficacy between the two intervention strategies.</div></div><div><h3>Trial registration</h3><div>ChiCTR, ChiCTR2000041520. Registered 27 December 2020, <span><span>https://www.chictr.org.cn/ChiCTR2000041520</span><svg><path></path></svg></span>. Retrospectively registered.</div></div>","PeriodicalId":49087,"journal":{"name":"Contact Lens & Anterior Eye","volume":"48 6","pages":"Article 102508"},"PeriodicalIF":3.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145082016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low-level light therapy alone versus combination therapy with intense pulsed light in the treatment of dry eye disease with meibomian gland dysfunction: A randomised paired-eye and mechanism of action trial 单独低强度光治疗与强脉冲光联合治疗伴有睑板腺功能障碍的干眼病:一项随机配对眼和作用机制试验
IF 3.7 3区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-12-01 DOI: 10.1016/j.clae.2025.102456
Jeremy Chung Bo Chiang , Viktor Dremin , David A Semp , Hiu Yan Lam , Patrick WK Ting , Moonisah Ayaz , James S Wolffsohn

Purpose

To investigate ocular surface changes following intense pulsed light therapy (IPL) combined with low level light therapy (LLLT) versus LLLT alone for the treatment of meibomian gland dysfunction (MGD) in patients with dry eye disease (DED).

Methods

Twenty-four participants with MGD and DED were recruited into a double-masked, paired-eye clinical trial, with one eye randomised to being treated with combined therapy and the other eye with LLLT alone across 4 treatment sessions, each 2 to 3 weeks apart. Follow-up assessments were also conducted at 2 weeks and then 3 months after the final treatment. Outcome measures included change in DED signs, symptomatology and in-vivo confocal microscopy parameters at final follow-up from baseline. Mechanism of action was explored with laser doppler flowmetry and fluorescence measures of the central lower eyelid.

Results

Symptom frequency rated with the Symptom Assessment Questionnaire in Dry Eye improved from baseline to final follow-up with combined therapy (mean difference − 21.6; 95 % CI − 38.5, −4.8; p = 0.005) and LLLT alone (−20.5; 95 % CI − 37.9, −3.1; p = 0.01), while symptom severity improved only with combined therapy (−18.5; 95 % CI − 34.5, −2.6; p = 0.01). Both modalities improved meibum expressibility following 3 treatment sessions, although improvement remained at final follow-up only with LLLT alone (−0.5, 95 % CI − 0.8, −0.2; p < 0.001). Tissue flavin fluorescence decreased after the fifth visit only with combined therapy (−12.7; 95 % CI − 4.9, 20.6; p = 0.001).

Conclusions

Combined therapy may have further mechanistic changes in increasing cellular metabolism, in addition to improvements in symptoms and meibum expressibility compared to LLLT alone. LLLT alone could be considered an adjunctive therapy for MGD if IPL is contraindicated.
目的:探讨强脉冲光治疗(IPL)联合弱光治疗(LLLT)与单用弱光治疗(LLLT)治疗干眼病(DED)患者睑板腺功能障碍(MGD)后眼表的变化。方法:24名患有MGD和DED的参与者被招募到一项双盲、配对眼的临床试验中,其中一只眼睛随机分配接受联合治疗,另一只眼睛单独接受LLLT治疗,共4次治疗,每次治疗间隔2至3周。在最终治疗后2周和3个月分别进行随访评估。结果测量包括从基线到最终随访时DED体征、症状学和体内共聚焦显微镜参数的变化。采用激光多普勒血流法和荧光法对下眼睑中心部位的作用机制进行了探讨。结果:干眼症症状评估问卷评分的症状频次从基线到联合治疗的最终随访有所改善(平均差值- 21.6;95% ci - 38.5, -4.8;p = 0.005)和LLLT单独(-20.5;95% ci - 37.9, -3.1;P = 0.01),而症状严重程度仅在联合治疗时改善(-18.5;95% ci - 34.5, -2.6;p = 0.01)。两种治疗方式在3次治疗后都改善了代谢因子的表达,尽管仅LLLT治疗在最后随访时仍有改善(-0.5,95% CI - 0.8, -0.2;结论:与单用LLLT相比,联合治疗除了改善症状和代谢表达外,还可能在增加细胞代谢方面有进一步的机制改变。如果IPL是禁忌症,单独的LLLT可以被认为是MGD的辅助治疗。
{"title":"Low-level light therapy alone versus combination therapy with intense pulsed light in the treatment of dry eye disease with meibomian gland dysfunction: A randomised paired-eye and mechanism of action trial","authors":"Jeremy Chung Bo Chiang ,&nbsp;Viktor Dremin ,&nbsp;David A Semp ,&nbsp;Hiu Yan Lam ,&nbsp;Patrick WK Ting ,&nbsp;Moonisah Ayaz ,&nbsp;James S Wolffsohn","doi":"10.1016/j.clae.2025.102456","DOIUrl":"10.1016/j.clae.2025.102456","url":null,"abstract":"<div><h3>Purpose</h3><div>To investigate ocular surface changes following intense pulsed light therapy (IPL) combined with low level light therapy (LLLT) versus LLLT alone for the treatment of meibomian gland dysfunction (MGD) in patients with dry eye disease (DED).</div></div><div><h3>Methods</h3><div>Twenty-four participants with MGD and DED were recruited into a double-masked, paired-eye clinical trial, with one eye randomised to being treated with combined therapy and the other eye with LLLT alone across 4 treatment sessions, each 2 to 3 weeks apart. Follow-up assessments were also conducted at 2 weeks and then 3 months after the final treatment. Outcome measures included change in DED signs, symptomatology and in-vivo confocal microscopy parameters at final follow-up from baseline. Mechanism of action was explored with laser doppler flowmetry and fluorescence measures of the central lower eyelid.</div></div><div><h3>Results</h3><div>Symptom frequency rated with the Symptom Assessment Questionnaire in Dry Eye improved from baseline to final follow-up with combined therapy (mean difference − 21.6; 95 % CI − 38.5, −4.8; p = 0.005) and LLLT alone (−20.5; 95 % CI − 37.9, −3.1; p = 0.01), while symptom severity improved only with combined therapy (−18.5; 95 % CI − 34.5, −2.6; p = 0.01). Both modalities improved meibum expressibility following 3 treatment sessions, although improvement remained at final follow-up only with LLLT alone (−0.5, 95 % CI − 0.8, −0.2; p &lt; 0.001). Tissue flavin fluorescence decreased after the fifth visit only with combined therapy (−12.7; 95 % CI − 4.9, 20.6; p = 0.001).</div></div><div><h3>Conclusions</h3><div>Combined therapy may have further mechanistic changes in increasing cellular metabolism, in addition to improvements in symptoms and meibum expressibility compared to LLLT alone. LLLT alone could be considered an adjunctive therapy for MGD if IPL is contraindicated.</div></div>","PeriodicalId":49087,"journal":{"name":"Contact Lens & Anterior Eye","volume":"48 6","pages":"Article 102456"},"PeriodicalIF":3.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144267766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Are scleral lenses underutilized? A call for greater awareness among healthcare professionals 巩膜晶状体是否未充分利用?呼吁医疗保健专业人员提高认识。
IF 3.7 3区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-12-01 DOI: 10.1016/j.clae.2025.102496
Maria K. Walker
{"title":"Are scleral lenses underutilized? A call for greater awareness among healthcare professionals","authors":"Maria K. Walker","doi":"10.1016/j.clae.2025.102496","DOIUrl":"10.1016/j.clae.2025.102496","url":null,"abstract":"","PeriodicalId":49087,"journal":{"name":"Contact Lens & Anterior Eye","volume":"48 6","pages":"Article 102496"},"PeriodicalIF":3.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145006796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical efficacy of induced epiphora by punctal plugging on refractory dry eye disease with ocular surface Damage: Randomized sham-controlled trial 点状封堵诱导眼显治疗难治性干眼病伴眼表损伤的临床疗效:随机假对照试验。
IF 3.7 3区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-12-01 DOI: 10.1016/j.clae.2025.102588
Hyunmin Ahn , Jae Lim Chung , Ikhyun Jun , Tae-im Kim , Kyoung Yul Seo

Purpose

To evaluate the efficacy of induced epiphora by punctal plug on refractory dry eye disease (DED) with ocular surface damage.

Methods

A 24-week, patient-masked, randomized, sham-controlled trial was conducted. Participants (n = 66) with refractory DED were randomized into treatment and control groups. The treatment group received silicone punctal plugs in both upper and lower eyelids and induced an overflow of tears, while the control group underwent a sham procedure. Efficacy was assessed through changes in Ocular Surface Disease Index (OSDI), SICCA corneal staining score (CSS) over time. Repeated measures ANOVA was performed to test the significance.

Results

At baseline, the mean OSDI of the overall participants was 34.1 ± 11.7, the mean CSS were 1.5 ± 0.7. The treatment group showed significant improvement in OSDI scores and reduction in CSS compared to the control group, starting as early as 3 weeks and increasing over the study period (all p < 0.05). At the 12- and 24-week follow-ups, 70 % achieved mild or lower OSDI scores. Complications of the treatment included plug dislodgement (39.4 %) and skin irritation (33.3 %). Over 90 % of participants reported being satisfied with the induced epiphora.

Conclusion

Induced epiphora by punctal plugging showed improvement in both subjective and objective outcomes in patients with refractory DED with ocular surface damage. This approach may serve as a potential adjunctive option for patients unresponsive to standard treatments, warranting careful application and longer-term evaluation.
目的:评价点状眼塞诱导眼珠脱落治疗伴有眼表损伤的难治性干眼病(DED)的疗效。方法:采用为期24周的患者盲、随机、假对照试验。难治性DED患者(n = 66)随机分为治疗组和对照组。治疗组在上、下眼睑植入硅胶点塞,诱导泪液溢出,而对照组则进行假手术。通过眼表疾病指数(OSDI)、SICCA角膜染色评分(CSS)随时间的变化来评估疗效。采用重复测量方差分析检验显著性。结果:在基线时,所有参与者的平均OSDI为34.1±11.7,平均CSS为1.5±0.7。与对照组相比,治疗组在OSDI评分和CSS评分上均有显著改善,且早在治疗3周时就开始了,并随着研究时间的推移而增加(均p)。结论:点状封堵诱导显泪对伴有眼表损伤的难治性DED患者的主观和客观结局均有改善。这种方法可以作为对标准治疗无反应的患者的潜在辅助选择,需要谨慎应用和长期评估。
{"title":"Clinical efficacy of induced epiphora by punctal plugging on refractory dry eye disease with ocular surface Damage: Randomized sham-controlled trial","authors":"Hyunmin Ahn ,&nbsp;Jae Lim Chung ,&nbsp;Ikhyun Jun ,&nbsp;Tae-im Kim ,&nbsp;Kyoung Yul Seo","doi":"10.1016/j.clae.2025.102588","DOIUrl":"10.1016/j.clae.2025.102588","url":null,"abstract":"<div><h3>Purpose</h3><div>To evaluate the efficacy of induced epiphora by punctal plug on refractory dry eye disease (DED) with ocular surface damage.</div></div><div><h3>Methods</h3><div>A 24-week, patient-masked, randomized, sham-controlled trial was conducted. Participants (n = 66) with refractory DED were randomized into treatment and control groups. The treatment group received silicone punctal plugs in both upper and lower eyelids and induced an overflow of tears, while the control group underwent a sham procedure. Efficacy was assessed through changes in Ocular Surface Disease Index (OSDI), SICCA corneal staining score (CSS) over time. Repeated measures ANOVA was performed to test the significance.</div></div><div><h3>Results</h3><div>At baseline, the mean OSDI of the overall participants was 34.1 ± 11.7, the mean CSS were 1.5 ± 0.7. The treatment group showed significant improvement in OSDI scores and reduction in CSS compared to the control group, starting as early as 3 weeks and increasing over the study period (all <em>p</em> &lt; 0.05). At the 12- and 24-week follow-ups, 70 % achieved mild or lower OSDI scores. Complications of the treatment included plug dislodgement (39.4 %) and skin irritation (33.3 %). Over 90 % of participants reported being satisfied with the induced epiphora.</div></div><div><h3>Conclusion</h3><div>Induced epiphora by punctal plugging showed improvement in both subjective and objective outcomes in patients with refractory DED with ocular surface damage. This approach may serve as a potential adjunctive option for patients unresponsive to standard treatments, warranting careful application and longer-term evaluation.</div></div>","PeriodicalId":49087,"journal":{"name":"Contact Lens & Anterior Eye","volume":"49 1","pages":"Article 102588"},"PeriodicalIF":3.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145662474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Specific clinical phenotypes of dry eye disease can predict the presence of matrix metalloproteinase-9 in the ocular surface 干眼病的特定临床表型可以预测基质金属蛋白酶-9在眼表的存在。
IF 3.7 3区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-12-01 DOI: 10.1016/j.clae.2025.102475
Germán Mejía-Salgado , William Rojas-Carabali , Carlos Cifuentes-González , Luis Alejandro Diez-Bahamón , Valentina Kerguelén-Dumar , Juanita Téllez-Zambrano , Juan José García-Madero , Alejandro Guevara-Carvajal , Martha Lucía Moreno-Pardo , Juliana Tirado-Ángel , Guillermo Marroquín-Gómez , Anat Galor , Alejandra de-la-Torre

Objective

The InflammaDry test detects matrix metalloproteinase-9 (MMP-9) in tears, a biomarker associated with ocular surface inflammation. While a positive result may indicate the need for anti-inflammatory therapy, its cost and qualitative nature limit widespread use. This study aims to identify clinical phenotypes that predict positive InflammaDry results, facilitating targeted anti-inflammatory therapy without requiring MMP-9 testing.

Methods

This retrospective study analyzed 1,363 patients with Dry Eye Disease (DED) from a dry eye clinic. Diagnosis was based on symptoms and at least one tear dysfunction sign. All patients underwent InflammaDry testing. Bivariate analysis (Chi-square, Student’s t-test, Mann-Whitney-U) identified clinical factors associated with test positivity, which were further analyzed in a multivariable model. The proportion of InflammaDry-positive patients was compared across groups with increasing numbers of risk factors.

Results

The mean age of the population was 51.4 years; 84.1 % were female, and all were Hispanic. Multivariable analysis identified several significant predictors of positive InflammaDry results: the presence of any autoimmune or allergic disease (odds ratio, OR = 1.59), corneal staining (Oxford ≥3, OR = 2.41), conjunctival staining (Oxford ≥3, OR = 2.30), low tear film viscosity (OR = 1.55), and nasal (OR 1.80) or temporal (OR = 1.47) ocular redness (Jenvis score >2 by Oculus). The frequency of a positive InflammaDry increased from 69.9 % in the total population (n = 1,363) to 100 % in those with three identified risk factors (n = 9).

Conclusion

Specific systemic and ocular phenotypes can predict InflammaDry test results. Patients with specific characteristics may not require MMP-9 testing due to the high likelihood of having a positive result, potentially leading to more targeted and cost-effective management strategies.
目的:InflammaDry检测泪液中的基质金属蛋白酶-9 (MMP-9),这是一种与眼表炎症相关的生物标志物。虽然阳性结果可能表明需要抗炎治疗,但其成本和定性性质限制了广泛使用。本研究旨在确定预测InflammaDry阳性结果的临床表型,从而在不需要检测MMP-9的情况下促进靶向抗炎治疗。方法:本回顾性研究分析了来自干眼诊所的1363例干眼病患者。诊断是基于症状和至少一个撕裂功能障碍体征。所有患者都进行了炎症检测。双变量分析(卡方检验、学生t检验、Mann-Whitney-U检验)确定了与检测阳性相关的临床因素,并在多变量模型中进一步分析。随着危险因素的增加,比较各组间炎症反应阳性患者的比例。结果:人口平均年龄为51.4岁;84.1%为女性,全部为西班牙裔。多变量分析确定了炎症阳性结果的几个重要预测因素:任何自身免疫性或过敏性疾病的存在(优势比,or = 1.59)、角膜染色(Oxford≥3,or = 2.41)、结膜染色(Oxford≥3,or = 2.30)、低泪膜粘度(or = 1.55)、鼻(or 1.80)或颞(or = 1.47)眼红肿(Oculus的Jenvis评分为bbbb2)。在具有三个确定的危险因素(n = 9)的人群中,InflammaDry阳性的频率从总人口的69.9% (n = 1363)增加到100%。结论:特异性的全身和眼部表型可以预测InflammaDry检测结果。具有特定特征的患者可能不需要检测MMP-9,因为阳性结果的可能性很高,这可能导致更有针对性和更具成本效益的管理策略。
{"title":"Specific clinical phenotypes of dry eye disease can predict the presence of matrix metalloproteinase-9 in the ocular surface","authors":"Germán Mejía-Salgado ,&nbsp;William Rojas-Carabali ,&nbsp;Carlos Cifuentes-González ,&nbsp;Luis Alejandro Diez-Bahamón ,&nbsp;Valentina Kerguelén-Dumar ,&nbsp;Juanita Téllez-Zambrano ,&nbsp;Juan José García-Madero ,&nbsp;Alejandro Guevara-Carvajal ,&nbsp;Martha Lucía Moreno-Pardo ,&nbsp;Juliana Tirado-Ángel ,&nbsp;Guillermo Marroquín-Gómez ,&nbsp;Anat Galor ,&nbsp;Alejandra de-la-Torre","doi":"10.1016/j.clae.2025.102475","DOIUrl":"10.1016/j.clae.2025.102475","url":null,"abstract":"<div><h3>Objective</h3><div>The InflammaDry test detects matrix metalloproteinase-9 (MMP-9) in tears, a biomarker associated with ocular surface inflammation. While a positive result may indicate the need for anti-inflammatory therapy, its cost and qualitative nature limit widespread use. This study aims to identify clinical phenotypes that predict positive InflammaDry results, facilitating targeted anti-inflammatory therapy without requiring MMP-9 testing.</div></div><div><h3>Methods</h3><div>This retrospective study analyzed 1,363 patients with Dry Eye Disease (DED) from a dry eye clinic. Diagnosis was based on symptoms and at least one tear dysfunction sign. All patients underwent InflammaDry testing. Bivariate analysis (Chi-square, Student’s <em>t</em>-test, Mann-Whitney-U) identified clinical factors associated with test positivity, which were further analyzed in a multivariable model. The proportion of InflammaDry-positive patients was compared across groups with increasing numbers of risk factors.</div></div><div><h3>Results</h3><div>The mean age of the population was 51.4 years; 84.1 % were female, and all were Hispanic. Multivariable analysis identified several significant predictors of positive InflammaDry results: the presence of any autoimmune or allergic disease (odds ratio, OR = 1.59), corneal staining (Oxford ≥3, OR = 2.41), conjunctival staining (Oxford ≥3, OR = 2.30), low tear film viscosity (OR = 1.55), and nasal (OR 1.80) or temporal (OR = 1.47) ocular redness (Jenvis score &gt;2 by Oculus). The frequency of a positive InflammaDry increased from 69.9 % in the total population (n = 1,363) to 100 % in those with three identified risk factors (n = 9).</div></div><div><h3>Conclusion</h3><div>Specific systemic and ocular phenotypes can predict InflammaDry test results. Patients with specific characteristics may not require MMP-9 testing due to the high likelihood of having a positive result, potentially leading to more targeted and cost-effective management strategies.</div></div>","PeriodicalId":49087,"journal":{"name":"Contact Lens & Anterior Eye","volume":"48 6","pages":"Article 102475"},"PeriodicalIF":3.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144650967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic effect of intense pulsed light in ocular demodicosis: A systematic review and meta-analysis 强脉冲光治疗眼蠕虫病的疗效:系统回顾和荟萃分析。
IF 3.7 3区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-12-01 DOI: 10.1016/j.clae.2025.102477
Hsin-Ming Liu , Shannon Su , Cher-Ming Liou , Ann Yi-Chiun Chuang

Aims

To assess the effect of intense pulsed light (IPL) on reducing ocular demodicosis.

Methods

A systematic literature search was conducted up to March 8, 2025, using the PubMed, Embase, Google Scholar, and Cochrane Central Register of Controlled Trials databases. Randomized controlled trials (RCTs) or non-RCTs with Demodex measurements before and after IPL therapy were included.

Results

Six trials (five RCTs + one non-RCT) involving 329 adults were included. The overall risk of bias was assessed as low to moderate, and the certainty of evidence for all outcomes was considered low. IPL reduced Demodex mites per 100 eyelashes, with a mean difference (MD) of −7.80 (−16.36 to 0.76) with moderate heterogeneity (p = 0.11, I2 = 47 %) when considering only RCTs. The risk ratio of Demodex eradication was 1.41 (1.18 to 1.69, I2 = 0 %, p = 0.72) and was significant in both the IPL with meibomian gland expression (MGX) subgroup (1.49, 1.17–1.91) and IPL alone subgroup (1.32, 1.02–1.72). No major adverse events were reported.

Conclusion

IPL, either alone or in combination with MGX, demonstrates a trend toward reducing Demodex infestation with no major adverse events reported. However, its effect on mite count reduction has not reached statistical significance. Further studies are needed to establish an optimal IPL treatment protocol.
目的:探讨强脉冲光(IPL)治疗眼部蠕虫病的效果。方法:使用PubMed、Embase、谷歌Scholar和Cochrane Central Register of Controlled Trials数据库进行系统文献检索,检索时间截止到2025年3月8日。纳入IPL治疗前后Demodex测量的随机对照试验(rct)或非rct。结果:纳入6项试验(5项rct + 1项非rct),涉及329名成年人。总体偏倚风险被评估为低至中等,所有结果的证据确定性被认为较低。仅考虑随机对照试验时,IPL每100根睫毛减少蠕形螨,平均差异(MD)为-7.80(-16.36至0.76),具有中等异质性(p = 0.11, I2 = 47%)。蠕形螨被根除的危险比为1.41 (1.18 ~ 1.69,I2 = 0%, p = 0.72),在有眉板腺表达的IPL (MGX)亚组(1.49,1.17 ~ 1.91)和单独IPL亚组(1.32,1.02 ~ 1.72)中均有显著性差异。无重大不良事件报告。结论:IPL,无论是单独使用还是与MGX联合使用,都显示出减少蠕形螨感染的趋势,没有重大不良事件的报道。但其对螨数的减少效果尚未达到统计学意义。需要进一步的研究来建立一个最佳的IPL治疗方案。
{"title":"Therapeutic effect of intense pulsed light in ocular demodicosis: A systematic review and meta-analysis","authors":"Hsin-Ming Liu ,&nbsp;Shannon Su ,&nbsp;Cher-Ming Liou ,&nbsp;Ann Yi-Chiun Chuang","doi":"10.1016/j.clae.2025.102477","DOIUrl":"10.1016/j.clae.2025.102477","url":null,"abstract":"<div><h3>Aims</h3><div>To assess the effect of intense pulsed light (IPL) on reducing ocular demodicosis.</div></div><div><h3>Methods</h3><div>A systematic literature search was conducted up to March 8, 2025, using the PubMed, Embase, Google Scholar, and Cochrane Central Register of Controlled Trials databases. Randomized controlled trials (RCTs) or non-RCTs with <em>Demodex</em> measurements before and after IPL therapy were included.</div></div><div><h3>Results</h3><div>Six trials (five RCTs + one non-RCT) involving 329 adults were included. The overall risk of bias was assessed as low to moderate, and the certainty of evidence for all outcomes was considered low. IPL reduced <em>Demodex</em> mites per 100 eyelashes, with a mean difference (MD) of −7.80 (−16.36 to 0.76) with moderate heterogeneity (<em>p</em> = 0.11, <em>I<sup>2</sup></em> = 47 %) when considering only RCTs. The risk ratio of <em>Demodex</em> eradication was 1.41 (1.18 to 1.69, <em>I<sup>2</sup></em> = 0 %, <em>p</em> = 0.72) and was significant in both the IPL with meibomian gland expression (MGX) subgroup (1.49, 1.17–1.91) and IPL alone subgroup (1.32, 1.02–1.72). No major adverse events were reported.</div></div><div><h3>Conclusion</h3><div>IPL, either alone or in combination with MGX, demonstrates a trend toward reducing <em>Demodex</em> infestation with no major adverse events reported. However, its effect on mite count reduction has not reached statistical significance. Further studies are needed to establish an optimal IPL treatment protocol.</div></div>","PeriodicalId":49087,"journal":{"name":"Contact Lens & Anterior Eye","volume":"48 6","pages":"Article 102477"},"PeriodicalIF":3.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144676267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Contact Lens & Anterior Eye
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1